Laurel Wealth Advisors (North Carolina)’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-125
Closed -$2K 539
2022
Q2
$2K Hold
125
﹤0.01% 521
2022
Q1
$3K Hold
125
﹤0.01% 526
2021
Q4
$5K Hold
125
﹤0.01% 474
2021
Q3
$6K Hold
125
﹤0.01% 448
2021
Q2
$4K Buy
125
+75
+150% +$2.4K ﹤0.01% 559
2021
Q1
$2K Buy
+50
New +$2K ﹤0.01% 592